SCHEMBL30487209

SCHEMBL30487209

N#Cc1ccc2c(c1)CC[C@H]2N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.44
LAP3 P28838 1/20 0.44
DPP4 P27487 1/20 0.43
DRD2 P14416 3/20 0.42
DRD3 P35462 3/20 0.42
PNMT P11086 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
LRRK2 Q5S007 4/20 0.41
CHRNA1 P02708 1/20 0.40
CHRNG P07510 1/20 0.40
CHRNB1 P11230 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
CHRND Q07001 1/20 0.40
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
NOS3 P29474 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131162 1.00 KDM1A (0.44) KDM1ALAP3DPP4DRD2DRD3
SCHEMBL8247897 1.00 KDM1A (0.44) KDM1ALAP3DPP4DRD2DRD3
SCHEMBL29809032 1.00 KDM1A (0.44) KDM1ALAP3DPP4DRD2DRD3
SCHEMBL30894874 1.00 KDM1A (0.44) KDM1ALAP3DPP4DRD2DRD3
SCHEMBL4154608 1.00 KDM1A (0.44) KDM1ALAP3DPP4DRD2DRD3
Hydrochloric Acid SCHEMBL4046623 0.98 LAP3 (0.46) KDM1ALAP3DPP4DRD2DRD3
Hydrochloric Acid SCHEMBL22371915 0.98 LAP3 (0.46) KDM1ALAP3DPP4DRD2DRD3
Hydrochloric Acid SCHEMBL1271612 0.98 LAP3 (0.46) KDM1ALAP3DPP4DRD2DRD3
Hydrochloric Acid SCHEMBL5270193 0.98 LAP3 (0.46) KDM1ALAP3DPP4DRD2DRD3
Hydrochloric Acid SCHEMBL29558222 0.98 LAP3 (0.46) KDM1ALAP3DPP4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11992494-B2 Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-05-28 US disclosed
CN-117813304-A Method for preparing alfukanitai 赛特凯恩蒂克公司 2024-04-02 CN disclosed
US-20230190763-A1 Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11992494-B2 Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists PTAFR, PDGFRA, PDGFRB KDM1A 4195/4885LAP3 2978/4885DPP4 2348/4885
US-20230190763-A1 Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists PTAFR, PDGFRA, PDGFRB KDM1A 4195/4885LAP3 2978/4885DPP4 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.